Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:41 pm Purchase |
2024-12-31 | 13G | IN8bio, Inc. INAB |
William Tai-Wei Ho | 4,098,800 5.600% |
972,295 (+31.10%) |
Filing History |
| 2025-02-14 4:29 pm Purchase |
2024-12-31 | 13G | IN8bio, Inc. INAB |
Alyeska Investment Group, L.P. | 7,241,076 9.900% |
7,241,076 (New Position) |
Filing History |
| 2025-01-31 4:05 pm Sale |
2024-12-31 | 13G | IN8bio, Inc. INAB |
HIRSCHMAN ORIN | 6,191,865 8.500% |
-546,067 (-8.10%) |
Filing History |
| 2024-10-11 6:01 pm Unchanged |
2024-10-04 | 13D | IN8bio, Inc. INAB |
BIOS Fund II LP | 10,416,165 23.100% |
0 (Unchanged) |
Filing History |
| 2024-10-09 5:19 pm Purchase |
2024-10-01 | 13G | IN8bio, Inc. INAB |
HIRSCHMAN ORIN | 6,737,932 9.300% |
4,403,264 (+188.60%) |
Filing History |
| 2024-09-17 7:30 pm Sale |
2024-06-14 | 13G | IN8bio, Inc. INAB |
HIRSCHMAN ORIN | 2,334,668 4.990% |
-1,763,693 (-43.03%) |
Filing History |
| 2024-02-13 4:04 pm Purchase |
2023-12-31 | 13G | IN8bio, Inc. INAB |
William Tai-Wei Ho | 3,126,505 7.100% |
225,606 (+7.78%) |
Filing History |
| 2023-12-15 4:31 pm Sale |
2023-12-13 | 13G | IN8bio, Inc. INAB |
Transcend Partners Opportunity Fund I LLC | 3,222,485 7.500% |
-889,473 (-21.63%) |
Filing History |
| 2023-12-15 06:26 am Purchase |
2023-12-11 | 13G | IN8bio, Inc. INAB |
HIRSCHMAN ORIN | 4,098,361 9.400% |
4,098,361 (New Position) |
Filing History |
| 2023-12-15 06:08 am Purchase |
2023-12-13 | 13D | IN8bio, Inc. INAB |
BIOS Fund II LP | 10,416,165 23.100% |
3,778,288 (+56.92%) |
Filing History |
| 2023-08-11 4:28 pm Purchase |
2021-12-31 | 13G | IN8bio, Inc. INAB |
William Tai-Wei Ho | 2,900,899 9.100% |
2,900,899 (New Position) |
Filing History |
| 2023-08-11 4:18 pm Purchase |
2021-08-03 | 13G | IN8bio, Inc. INAB |
Transcend Partners Opportunity Fund I LLC | 4,111,958 13.000% |
4,111,958 (New Position) |
Filing History |
| 2021-08-13 4:16 pm Purchase |
2021-08-03 | 13D | IN8bio, Inc. INAB |
BIOS Fund II LP | 6,637,877 35.400% |
6,637,877 (New Position) |
Filing History |